Objective: To describe the use of oral mycophenolate mofetil (MMF) as an adjunctive therapy in 2 cats with primary immune-mediated hemolytic anemia.
Case Series Summary: Two cats suffering from presumptive primary immune mediated hemolytic were treated with MMF as part of their treatment regimens. Both cats had improved complete blood counts following therapy.
New Or Unique Information Provided: This is the first reported use of oral MMF as adjunctive treatment for cats with immune-mediated hemolytic anemia. Outcome was favorable in both cats and no adverse effects were noted from the MMF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1476-4431.2010.00606.x | DOI Listing |
Publication Analysis
Top Keywords
immune-mediated hemolytic
12
primary immune-mediated
8
hemolytic anemia
8
mycophenolate mofetil
8
mmf adjunctive
8
cats
6
treatment primary
4
hemolytic
4
anemia mycophenolate
4
mofetil cats
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!